The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial

被引：0
|
作者：
Shabbir, S. [1 ]
Pouliquen, I. [2 ]
Bentley, J. H. [3 ]
Bradford, E. S. [4 ]
Kaisermann, M. C. [5 ]
Albayaty, M. [6 ]
机构：
[1] GSK, Clin Platforms & Sci PCPS, Global Clin Sci & Delivery GCSD R&D Projects, Stevenage, Herts, England
[2] GSK, Clin Pharmacol Modelling & Simulat, Uxbridge, Middx, England
[3] GSK, Clin Stat, Uxbridge, Middx, England
[4] GSK, Resp Therapeut Area, Res Triangle Pk, NC USA
[5] GSK, Resp Therapy Area, Collegeville, PA USA
[6] Northwick Pk Hosp & Clin Res Ctr, PAREXEL Early Phase Clin Unit, Harrow, Middx, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
基金：
芬兰科学院;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1311
引用
收藏
页数：2
相关论文
共 50 条
  • [41] An open-label, randomized, crossover study to evaluate the bioavailability of nanoemulsion versus conventional fat-soluble formulation of cholecalciferol in healthy participants
    Marwaha, Raman Kumar
    Verma, Manish
    Walekar, Ajit
    Sonawane, Rakesh
    Trivedi, Chirag
    JOURNAL OF ORTHOPAEDICS, 2023, 35 : 64 - 68
  • [42] Pharmacokinetics of a New Orally Disintegrating Tablet Formulation of Aripiprazole 15 mg Administered Without Water in Healthy Middle-aged Korean Subjects
    Kim, Yunjeong
    Jeon, Ji-Young
    Chung, Young-Chul
    Kim, Min-Gul
    CLINICAL THERAPEUTICS, 2015, 37 (12) : 2772 - 2779
  • [43] RANDOMIZED CROSSOVER TRIAL TO EXAMINE THE SAFETY AND PHARMACOKINETICS OF 2100 MG DOSE OF AQ-13 AND THE FOOD EFFECT ON ITS BIOAVAILABILITY
    Mzayek, Fawaz
    Deng, Haiyan
    Mave, Vidya
    Hadi, Azam
    Lertora, Juan J.
    Krogstad, Donald J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 224 - 224
  • [44] Enhanced bioavailability and pharmacokinetics of a novel hybrid-hydrogel formulation of fisetin orally administered in healthy individuals: a randomised double-blinded comparative crossover study
    Krishnakumar, Illathu Madhavamenon
    Jaja-Chimedza, Asha
    Joseph, Ashil
    Balakrishnan, Abhilash
    Maliakel, Balu
    Swick, Andrew
    JOURNAL OF NUTRITIONAL SCIENCE, 2022, 11
  • [45] RELATIVE BIOAVAILABILITY OF TWO FORMULATIONS CONTAINING DAPAGLIFLOZIN 10 MG UNDER FED CONDITION IN A RANDOMIZED CROSSOVER STUDY IN HEALTHY CAUCASIAN SUBJECTS
    Oroian, Monica
    Pop, Diana Ioana
    Gheldiu, Ana-Maria
    Bhardwaj, Sandeep
    Marcovici, Adriana
    Khuroo, Arshad
    Vlase, Laurian
    FARMACIA, 2020, 68 (01) : 76 - 81
  • [46] Opicapone effect on levodopa pharmacokinetics in comparison with placebo and entacapone when administered with immediate release 100/25 mg levodopa/carbidopa in healthy subjects
    Rocha, J. F.
    Falcao, A.
    Lopes, N.
    Pinto, R.
    Santos, A.
    Nunes, T.
    Soares-da-Silva, P.
    JOURNAL OF NEUROLOGY, 2014, 261 : S119 - S119
  • [47] PHARMACOKINETICS AND BIOAVAILABILITY OF A SUSTAINED-RELEASE DILTIAZEM FORMULATION (MONO-TILDIEM LP 300 MG) AFTER REPEATED ADMINISTRATION IN HEALTHY-VOLUNTEERS
    BIANCHETTI, G
    DUBRUC, C
    SULTANA, V
    HOUIN, G
    ROSENZWEIG, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (3-4) : 259 - 264
  • [48] Pharmacokinetics and bioequivalence of a molnupiravir tablet formulation compared with the molnupiravir capsule formulation in healthy adult participants-a randomized, open-label, three-period, crossover study
    Fiore, Julie L.
    Jin, Yoon
    Heimbach, Tycho
    Patel, Shruti R.
    Zhao, Tian
    Matthews, Catherine Z.
    Pagnussat, Sandra
    Maas, Brian M.
    Cheng, Mickie H.
    Stoch, S. Aubrey
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2025, 69 (03)
  • [49] Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose-a randomized controlled trial
    Skulberg, Arne Kristian
    Asberg, Anders
    Khiabani, Hasse Zare
    Rostad, Hilde
    Tylleskar, Ida
    Dale, Ola
    ADDICTION, 2019, 114 (05) : 859 - 867
  • [50] Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once-weekly basal insulin, in healthy participants: A randomized trial
    Tang, Chengyong
    Su, Rui
    Wan, Lei
    Zhu, Mingxue
    Pu, Junliang
    Hao, Chunyue
    Zhao, Jing
    He, Anshun
    Xie, Tian
    Li, Yue
    Chen, Wei
    Gan, Zhong-Ru
    DIABETES OBESITY & METABOLISM, 2025,
12345